These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8800448)

  • 1. A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma.
    Ichiya Y; Kuwabara Y; Sasaki M; Yoshida T; Omagari J; Akashi Y; Kawashima A; Fukumura T; Masuda K
    Ann Nucl Med; 1996 May; 10(2):193-200. PubMed ID: 8800448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.
    Ichiya Y; Kuwabara Y; Otsuka M; Tahara T; Yoshikai T; Fukumura T; Jingu K; Masuda K
    J Nucl Med; 1991 Sep; 32(9):1655-60. PubMed ID: 1880564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma.
    Hellwig D; Graeter TP; Ukena D; Georg T; Kirsch CM; Schäfers HJ
    J Thorac Cardiovasc Surg; 2004 Dec; 128(6):892-9. PubMed ID: 15573074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography.
    Erasmus JJ; Patz EF; McAdams HP; Murray JG; Herndon J; Coleman RE; Goodman PC
    AJR Am J Roentgenol; 1997 May; 168(5):1357-60. PubMed ID: 9129444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.
    Frank A; Lefkowitz D; Jaeger S; Gobar L; Sunderland J; Gupta N; Scott W; Mailliard J; Lynch H; Bishop J
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1495-512. PubMed ID: 7635795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET).
    Duhaylongsod FG; Lowe VJ; Patz EF; Vaughn AL; Coleman RE; Wolfe WG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):130-9; discussion 139-40. PubMed ID: 7609536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose.
    Patz EF; Lowe VJ; Hoffman JM; Paine SS; Harris LK; Goodman PC
    Radiology; 1994 May; 191(2):379-82. PubMed ID: 8153309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of abnormal FDG uptake by various histological types of non-small cell lung cancer at initial staging by PET.
    Wong CY; Nuñez R; Bohdiewicz P; Welsh RJ; Chmielewski GW; Ravikrishnan KP; Hill JC; Pursel SE; Fink-Bennett D; Balon H; Dickinson C; Dworkin HJ
    Eur J Nucl Med; 2001 Nov; 28(11):1702-5. PubMed ID: 11702114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The predictive value of
    Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
    Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation analysis of [
    Di Perri D; Lee JA; Bol A; Hanin FX; Janssens G; Labar D; Robert A; Sterpin E; Geets X
    Acta Oncol; 2017 Sep; 56(9):1181-1188. PubMed ID: 28537761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation.
    Greven KM; Williams DW; Keyes JW; McGuirt WF; Watson NE; Randall ME; Raben M; Geisinger KR; Cappellari JO
    Cancer; 1994 Aug; 74(4):1355-9. PubMed ID: 8055460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.
    Sazon DA; Santiago SM; Soo Hoo GW; Khonsary A; Brown C; Mandelkern M; Blahd W; Williams AJ
    Am J Respir Crit Care Med; 1996 Jan; 153(1):417-21. PubMed ID: 8542152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer.
    Chin AL; Kumar KA; Guo HH; Maxim PG; Wakelee H; Neal JW; Diehn M; Loo BW; Gensheimer MF
    Clin Lung Cancer; 2018 Sep; 19(5):e581-e588. PubMed ID: 29759331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [18F] 3-deoxy-3'-fluorothymidine positron emission tomography: alternative or diagnostic adjunct to 2-[18f]-fluoro-2-deoxy-D-glucose positron emission tomography in the workup of suspicious central focal lesions?
    Halter G; Buck AK; Schirrmeister H; Wurziger I; Liewald F; Glatting G; Neumaier B; Sunder-Plassmann L; Reske SN; Hetzel M
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1093-9. PubMed ID: 15052207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tc-99m MIBI scintigraphy in patients with lung cancer. Comparison with CT and fluorine-18 FDG PET imaging.
    Wang H; Maurea S; Mainolfi C; Fiore F; Gravina A; Panico MR; Bazzicalupo L; Salvatore M
    Clin Nucl Med; 1997 Apr; 22(4):243-9. PubMed ID: 9099482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of pulmonary nodules and mediastinal staging of bronchogenic carcinoma with F-18 fluorodeoxyglucose positron emission tomography.
    Hagberg RC; Segall GM; Stark P; Burdon TA; Pompili MF
    Eur J Cardiothorac Surg; 1997 Jul; 12(1):92-7. PubMed ID: 9262087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy.
    Pyka T; Bundschuh RA; Andratschke N; Mayer B; Specht HM; Papp L; Zsótér N; Essler M
    Radiat Oncol; 2015 Apr; 10():100. PubMed ID: 25900186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma.
    Patz EF; Lowe VJ; Goodman PC; Herndon J
    Chest; 1995 Dec; 108(6):1617-21. PubMed ID: 7497771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between non-small cell lung cancer FDG uptake at PET, tumor histology, and Ki-67 proliferation index.
    Vesselle H; Salskov A; Turcotte E; Wiens L; Schmidt R; Jordan CD; Vallières E; Wood DE
    J Thorac Oncol; 2008 Sep; 3(9):971-8. PubMed ID: 18758298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Ablative Radiation Therapy for Lung Oligometastases: Predictive Parameters of Early Response by
    Mazzola R; Fiorentino A; Di Paola G; Giaj Levra N; Ricchetti F; Fersino S; Tebano U; Pasetto S; Ruggieri R; Salgarello M; Alongi F
    J Thorac Oncol; 2017 Mar; 12(3):547-555. PubMed ID: 28126325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.